Home › Research › What the research found › Every row
Every row of the evidence table
One row per finding: what was tested, which way the result went, and how the study was built. The answer by area, and where the studies disagree, are on the main page.
Every row
Filter
Showing 3 of 382 rows. One row per study per exposure: a study that tested two different things appears twice, once for each.
Scroll the table sideways to see every column.
| Exposure | Question | Direction | Outcome measured | Design | People | Effect size, as the source reported it | Source |
|---|---|---|---|---|---|---|---|
| Polygenic risk / GWAS loci Genes (not modifiable) | Prevention |
Harm
whyDirection is for a high polygenic score (excluding APOE): people in the top decile had a twofold risk of Braak stage >4 tangles and of moderate-to-severe amyloid plaque pathology at death. 91 loci identified, 16 new; 18 further loci await validation. |
Genome-wide risk loci and a polygenic score's association with tau and amyloid pathology at death | meta-analysis | 978,514 | We identified 91 genetic loci associated with ADRD risk, of which 16 are new and 56 are specifically detected in clinically diagnosed AD cases ... Individuals in the tenth decile of the score exhibited a twofold increased risk of presenting with Braak neurofibrillary tangles stage of >4 and moderate-to-severe neuritic amyloid plaque pathology at death compared to individuals in the median score group |
Nature Genetics
2026 ✓ Peer-reviewed PMID 42237039 |
| Polygenic risk / GWAS loci Genes (not modifiable) | Prevention |
No direction reported
whyLocus-discovery genome-wide association study: it reports which genetic regions reached significance and no effect estimate for any exposure, so no direction is recorded. The study reports 14 new loci for clinically diagnosed AD and two from AD-by-proxy. |
Genome-wide significant loci for clinically diagnosed AD and AD-by-proxy | meta-analysis | 432,374 | not established — pubmed abstract lists the loci by name and reports no effect estimate. |
Alzheimer's & Dementia
2025 ✓ Peer-reviewed PMID 39998322 |
| Polygenic risk / GWAS loci Genes (not modifiable) | Prevention |
Harm
whyDirection is for carrying a higher genetic risk score: risk of AD rose 1.6- to 1.9-fold from the lowest to the highest decile, over and above age and APOE4. The main output is 75 risk loci, 42 new. |
Genome-wide risk loci and a genetic risk score for future AD/dementia | meta-analysis | 788,989 | We found 75 risk loci, of which 42 were new at the time of analysis ... The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele |
Nature Genetics
2022 ✓ Peer-reviewed PMID 35379992 |